Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

1.4K
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.4K
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

13
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
13
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Dementia l: Introduction01:22

Dementia l: Introduction

29
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
29

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuropsychological Tests for Detecting Prodromal DLB: A Systematic Review.

European journal of neurology·2026
Same author

Sustained attention in dementia with Lewy bodies: a task-based fMRI study.

Frontiers in aging neuroscience·2026
Same author

Commonalities and Divergences in the Cognitive Profiles of Autism and Dementia: Protocol for a Narrative Literature Review.

JMIR research protocols·2026
Same author

The role of quantitative susceptibility mapping in dementia with Lewy Bodies.

NeuroImage. Clinical·2026
Same author

Exploring Information Access in Aging Populations and Those With Dementia and Mild Cognitive Impairment in the United Kingdom: Survey and Focus Group Study.

JMIR aging·2026
Same author

Organizational principles of the cerebral cortex predict symptoms progression in the Alzheimer's disease spectrum.

NeuroImage·2026

Related Experiment Video

Updated: Apr 24, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

18.2K

Differentiating normal from pathological brain ageing using standard neuropsychological tests.

Sarah J Wakefield, William J McGeown, Michael F Shanks

  • 1Department of Neuroscience, Medical School, Beech Hill Road, Sheffield, S10 2RX, UK. a.venneri@sheffield.ac.uk.

Current Alzheimer Research
|September 13, 2014
PubMed
Summary
This summary is machine-generated.

Verbal fluency tests effectively distinguish early Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI) from normal aging. Long-term memory decline is common in aging and not specific to early AD.

More Related Videos

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
10:13

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach

Published on: February 14, 2014

12.4K
Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

6.3K

Related Experiment Videos

Last Updated: Apr 24, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

18.2K
Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
10:13

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach

Published on: February 14, 2014

12.4K
Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

6.3K

Area of Science:

  • Neuropsychology
  • Neurology
  • Gerontology

Background:

  • Early diagnosis of Alzheimer's disease (AD) requires tests sensitive to neuropathology but not normal aging.
  • Distinguishing Mild Cognitive Impairment (MCI) and early AD from typical aging is crucial for timely intervention.

Purpose of the Study:

  • To identify neuropsychological tests that best differentiate between normal aging, MCI, and early AD.
  • To evaluate the utility of long-term memory and verbal fluency tests in diagnosing early neurodegenerative changes.

Main Methods:

  • Administered various neuropsychological tests to young controls, older adults, individuals with MCI, and early AD patients.
  • Analyzed performance on long-term memory recall and verbal fluency tasks.
  • Compared test results across different age and cognitive status groups.

Main Results:

  • Long-term memory impairments were observed in older adults, with greater deficits in MCI and early AD groups.
  • Older adults outperformed young controls in verbal fluency, producing more words that were less familiar and later acquired.
  • Impaired verbal fluency was significantly associated with both established AD and the prodromal MCI stage, unlike long-term memory decline.

Conclusions:

  • Verbal fluency tests are sensitive to the prodromal (MCI) and early stages of Alzheimer's disease, offering a reliable method for differentiation from normal aging.
  • Long-term memory decline is not a specific indicator for differentiating early AD from normal aging due to its prevalence in the general older population.